Lacie C. Pecha, PHARMD
Pharmacist · Omaha, NE
Lacie C. Pecha, PHARMD is a pharmacist with a practice address in Omaha, Nebraska, and NPI 1821827494, issued on Jul 31, 2024. Check the license (Nebraska 18345, as entered in NPPES) with the Nebraska board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Lacie C. Pecha
- Credential
- PHARMD
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 18345 NE
Self-reported in NPPES; status is on the state search - Practice location
- 15525 Spaulding Plz, Omaha, NE 68116
- Phone
- (402) 408-1087
- Enumerated
- Jul 31, 2024
- Record last updated
- Jul 31, 2024
- Entity
- Type 1 · individual
Also registered at 15525 Spaulding Plz
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Yazen AlnoutiPharmacist1841029477
- Panayiota Anastasiou, PHARMDPharmacist1215204441
- Vasanta ChigurupatiPharmacist1760009252
- Martin McConaughy, RPHPharmacist1295005064
- Laurel Robinson, PHARMDPharmacist1952657884
Verify Lacie C. Pecha in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Nebraska board licenses this profession
Search for license 18345Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
82% fewer Medicare Part D claims than the average pharmacist in 2024
21 Medicare Part D claims for 19 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
748 pharmacist records list a practice address in Omaha
They are 748 of the 33,911 NPPES records with a practice address in Omaha, and 1,815 pharmacist records in Nebraska.
All 748 in Omaha → All 1,815 in Nebraska → Every provider in Omaha →
Other pharmacist records in Nebraska
- Meiran AbdelhamidOmaha, NE1124797949
- Austin AbelardeOmaha, NE1578852638
- Rouba Abukwaik, PHARM DOmaha, NE1285257808
- Therese Acamo, PHARM.D.Elkhorn, NE1043436587
- Melissa AdamOmaha, NE1689082745
- Michael Adam, RPHOmaha, NE1922384866
- Amy Adams, PHARM DOmaha, NE1124148192
- Megan Aden, PHARMDOmaha, NE1144994591
- Edward AhernOmaha, NE1265860837
- Dyan AirenOmaha, NE1669197711
Common questions
What is Lacie C. Pecha, PHARMD's NPI number?
Lacie C. Pecha, PHARMD's National Provider Identifier (NPI) is 1821827494, issued on Jul 31, 2024. An NPI identifies a provider in billing; it is not a license.
Where is Lacie C. Pecha, PHARMD located?
The NPPES record lists a practice address at 15525 Spaulding Plz, Omaha, NE, 68116. Phone: (402) 408-1087. Providers update this record themselves, so call before visiting.
How can I verify Lacie C. Pecha, PHARMD's license?
NPPES lists Nebraska license number 18345, as entered by the provider. Search the Nebraska board that licenses this profession; the NPPES record confirms identity only.
How much does Lacie C. Pecha, PHARMD prescribe under Medicare Part D?
In 2024, Lacie C. Pecha, PHARMD had 21 Medicare Part D claims for 19 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.